There is a critical need for safe and effective treatments for secondary progressive multiple sclerosis (SPMS), a highly debilitating [...]
It is with a heavy heart that IOMSN announces the passing of Nicola "Nicki" Ward-Abel. Nicki was a founding member of IOMSN via our UK [...]
Researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the disease and potentially [...]
Researchers have apparently found a way to help predict multiple sclerosis disease progression one year after an initial [...]
Researchers at Northwestern University are seeking volunteers to participate in the pilot testing of a new quality measure for [...]
When the following headline in the Australian newspaper the Herald Sun caught my eye recently, I was cautiously intrigued: “Doctors [...]
PDF ROCKLAND, Mass., July 30, 2018 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and [...]
